GPCRs are one of the most important targets in drug design because they are involved in many critical physiological processes. Approximately 30-40% of all marketed drugs target GPCRs. Understanding GPCR-mediated pathways allows researchers to develop drugs that can either mimic or block the action of natural ligands, leading to therapeutic benefits or mitigation of toxic effects.
